Survival analysis among lung cancer patients in Pahang

November 2009. Patients with histology confi rmed lung cancer were recruited in the study. Survival time was defi ned from the date of histological diagnosis to time of death. Data on patients’ characteristic, ECOG functional status, staging, treatment were obtained. Kaplan Meier was used to meas...

Full description

Bibliographic Details
Main Authors: Ng, Teck Han, How, Soon Hin, Kuan, Yeh Chunn, Ab Rahman, Jamalludin, Abdul Rani, Mohammed Fauzi
Format: Article
Language:English
Published: Wiley-Blackwell 2010
Subjects:
Online Access:http://irep.iium.edu.my/21993/
http://irep.iium.edu.my/21993/1/Ng_Teck_Han_j.1440-1843.2010.01865.x.pdf
id iium-21993
recordtype eprints
spelling iium-219932016-03-10T07:09:29Z http://irep.iium.edu.my/21993/ Survival analysis among lung cancer patients in Pahang Ng, Teck Han How, Soon Hin Kuan, Yeh Chunn Ab Rahman, Jamalludin Abdul Rani, Mohammed Fauzi R Medicine (General) RA Public aspects of medicine November 2009. Patients with histology confi rmed lung cancer were recruited in the study. Survival time was defi ned from the date of histological diagnosis to time of death. Data on patients’ characteristic, ECOG functional status, staging, treatment were obtained. Kaplan Meier was used to measure the survival status and compared using log-rank test. Relevant factors were included in Cox Proportional Hazard Regression to identify independent factors affecting the survival of lung cancer patient. Results Of a total of 100 patients enrolled in this study, 81% were males and 82% were smokers. The age ranges from 30 to 83 years with mean (SD) age of 59.6 (11.3) years. There were 68 Malays, 27 Chinese, 3 Indians and 2 Arbogines. ECOG of 0 or 1, 2 and 3 or 4 were found in 47%, 19% and 34% respectively. All patients presented with either stage 3 or 4 (47% in stage 4). Only 45% patients received conventional chemotherapy. Overall, median (SE) survival was 14.8 (3.5) weeks. There were no signifi cant differences in median survival among males vs females, smokers vs non-smokers, Malays vs non- Malays, stage 3 vs stage 4. However, patients with ECOG 0 or 1 had longer median survival than patients with ECOG 2 or more (35.3 week vs 8.9 weeks, p < 0.001). Patients given chemotherapy also had longer median survival than those without chemotherapy (37.4 weeks vs 4.9 weeks, p < 0.001). On multivariate analysis, when all these factor were included in the regression model, only smoker and patients on best supportive care alone were the signifi cant independent negative prognostic factors affecting survival. Conclusion Patients of good performance status of ECOG 0/1 and given chemotherapy were associated with better survival in lung cancer patients. Wiley-Blackwell 2010-11 Article PeerReviewed application/pdf en http://irep.iium.edu.my/21993/1/Ng_Teck_Han_j.1440-1843.2010.01865.x.pdf Ng, Teck Han and How, Soon Hin and Kuan, Yeh Chunn and Ab Rahman, Jamalludin and Abdul Rani, Mohammed Fauzi (2010) Survival analysis among lung cancer patients in Pahang. Respirology, 15 (2). p. 72. ISSN 1323-7799
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic R Medicine (General)
RA Public aspects of medicine
spellingShingle R Medicine (General)
RA Public aspects of medicine
Ng, Teck Han
How, Soon Hin
Kuan, Yeh Chunn
Ab Rahman, Jamalludin
Abdul Rani, Mohammed Fauzi
Survival analysis among lung cancer patients in Pahang
description November 2009. Patients with histology confi rmed lung cancer were recruited in the study. Survival time was defi ned from the date of histological diagnosis to time of death. Data on patients’ characteristic, ECOG functional status, staging, treatment were obtained. Kaplan Meier was used to measure the survival status and compared using log-rank test. Relevant factors were included in Cox Proportional Hazard Regression to identify independent factors affecting the survival of lung cancer patient. Results Of a total of 100 patients enrolled in this study, 81% were males and 82% were smokers. The age ranges from 30 to 83 years with mean (SD) age of 59.6 (11.3) years. There were 68 Malays, 27 Chinese, 3 Indians and 2 Arbogines. ECOG of 0 or 1, 2 and 3 or 4 were found in 47%, 19% and 34% respectively. All patients presented with either stage 3 or 4 (47% in stage 4). Only 45% patients received conventional chemotherapy. Overall, median (SE) survival was 14.8 (3.5) weeks. There were no signifi cant differences in median survival among males vs females, smokers vs non-smokers, Malays vs non- Malays, stage 3 vs stage 4. However, patients with ECOG 0 or 1 had longer median survival than patients with ECOG 2 or more (35.3 week vs 8.9 weeks, p < 0.001). Patients given chemotherapy also had longer median survival than those without chemotherapy (37.4 weeks vs 4.9 weeks, p < 0.001). On multivariate analysis, when all these factor were included in the regression model, only smoker and patients on best supportive care alone were the signifi cant independent negative prognostic factors affecting survival. Conclusion Patients of good performance status of ECOG 0/1 and given chemotherapy were associated with better survival in lung cancer patients.
format Article
author Ng, Teck Han
How, Soon Hin
Kuan, Yeh Chunn
Ab Rahman, Jamalludin
Abdul Rani, Mohammed Fauzi
author_facet Ng, Teck Han
How, Soon Hin
Kuan, Yeh Chunn
Ab Rahman, Jamalludin
Abdul Rani, Mohammed Fauzi
author_sort Ng, Teck Han
title Survival analysis among lung cancer patients in Pahang
title_short Survival analysis among lung cancer patients in Pahang
title_full Survival analysis among lung cancer patients in Pahang
title_fullStr Survival analysis among lung cancer patients in Pahang
title_full_unstemmed Survival analysis among lung cancer patients in Pahang
title_sort survival analysis among lung cancer patients in pahang
publisher Wiley-Blackwell
publishDate 2010
url http://irep.iium.edu.my/21993/
http://irep.iium.edu.my/21993/1/Ng_Teck_Han_j.1440-1843.2010.01865.x.pdf
first_indexed 2023-09-18T20:33:37Z
last_indexed 2023-09-18T20:33:37Z
_version_ 1777408899353149440